Steelhead Wealth Management LLC bought a new stake in Bowhead Specialty Holdings Inc. (NYSE:BOW – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 95,569 shares of the company’s stock, valued at approximately $2,143,000. Bowhead Specialty comprises about 1.1% of Steelhead Wealth Management LLC’s investment portfolio, making the stock its 23rd biggest position. Steelhead Wealth Management LLC owned approximately 0.29% of Bowhead Specialty at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the business. Langdon Equity Partners acquired a new position in Bowhead Specialty in the fourth quarter valued at approximately $28,000. Raymond James Financial Inc. acquired a new stake in Bowhead Specialty during the 2nd quarter worth $52,000. CWM LLC raised its position in shares of Bowhead Specialty by 257.7% during the 4th quarter. CWM LLC now owns 1,481 shares of the company’s stock valued at $42,000 after acquiring an additional 1,067 shares during the last quarter. Parallel Advisors LLC raised its position in shares of Bowhead Specialty by 181.4% during the 1st quarter. Parallel Advisors LLC now owns 1,652 shares of the company’s stock valued at $37,000 after acquiring an additional 1,065 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Bowhead Specialty by 99.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,926 shares of the company’s stock valued at $72,000 after purchasing an additional 958 shares during the period.
Bowhead Specialty Price Performance
BOW opened at $30.61 on Monday. The stock has a market cap of $1.01 billion, a P/E ratio of 17.70, a P/E/G ratio of 0.92 and a beta of -0.10. Bowhead Specialty Holdings Inc. has a 12 month low of $21.21 and a 12 month high of $33.20. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $29.00 and a 200 day simple moving average of $26.07.
Analysts Set New Price Targets
Several research analysts have recently issued reports on BOW shares. Citizens Jmp reduced their price target on Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a research report on Monday, April 13th. UBS Group set a $28.00 price objective on Bowhead Specialty in a report on Thursday, May 21st. JPMorgan Chase & Co. increased their target price on Bowhead Specialty from $30.00 to $33.00 and gave the company a “neutral” rating in a research note on Monday, July 20th. Royal Bank Of Canada raised their target price on Bowhead Specialty from $30.00 to $38.00 and gave the stock an “outperform” rating in a report on Monday, July 13th. Finally, Morgan Stanley boosted their target price on Bowhead Specialty from $28.00 to $30.00 and gave the stock an “equal weight” rating in a research report on Monday, July 6th. Five investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Bowhead Specialty has a consensus rating of “Moderate Buy” and a consensus target price of $33.71.
Read Our Latest Analysis on BOW
About Bowhead Specialty
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Stories
- Five stocks we like better than Bowhead Specialty
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
